| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $16.3B | $15.4B | $15.0B | $14.4B | $13.9B | $3.3B | $2.9B | $2.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.0B | $2.0B | $2.1B | $2.1B | $2.0B | $1.8B | $1.7B | $1.7B |
| Operating Income | $2.2B | $2.2B | $2.0B | $1.8B | $1.4B | $0.3B | $0.2B | $0.2B |
| Net Income | $1.4B | $1.4B | $1.4B | $1.1B | $1.0B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $7.91 | $7.57 | $7.39 | $5.82 | $5.05 | $0.62 | $0.09 | $0.34 |
| EPS (Diluted) | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $0.61 | $0.09 | $0.34 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.9B | $26.9B | $26.7B | $25.3B | $24.7B | $24.6B | $23.3B | $22.5B |
| Current Assets | $6.2B | $5.8B | $5.6B | $5.0B | $4.8B | $5.1B | $4.1B | $3.9B |
| Cash & Equivalents | $2.0B | $1.7B | $1.4B | $1.2B | $1.4B | $1.8B | $0.8B | $0.9B |
| Total Liabilities | $23.3B | $20.8B | $20.6B | $19.6B | $18.6B | $18.3B | $17.0B | $15.6B |
| Current Liabilities | $8.3B | $7.0B | $6.5B | $5.6B | $5.2B | $4.6B | $3.9B | $3.5B |
| Stockholders' Equity | $6.5B | — | — | — | $6.0B | $6.0B | $6.0B | $6.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.7B | $2.7B | $2.1B | $2.3B | $2.9B | $2.0B | $1.4B | $1.3B |
| Investing Cash Flow | $-2.3B | $-1.4B | $-1.6B | $-2.0B | $-2.1B | $-0.8B | $-1.2B | $-0.8B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.1B | $-0.9B | $-0.4B | $-0.3B | $-1.2B | $-0.2B | $-0.3B | $-0.5B |